Skip to main content

Castleview Partners, LLC

SEC CIK
0001737088
Latest filing
Jul 20, 2026

ESPR holding history

Esperion Therapeutics, Inc. in every 13F filed by Castleview Partners, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ESPR overviewAll 13F holders of ESPRFull Q2 2026 holdings

Shares (Q3 2024)
0
Sold out in Q3 2024
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q2 2024
Holdings of ESPR by Castleview Partners, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20240$00.0%−27,374−100.0%Sold outHolders
Q2 202427,374$60.8K<0.1%+27,374NewHolders